Stillwater Capital Advisors’s Eli Lilly LLY Stock Holding History

Stillwater Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.3M	Sell	34,051 -315	-0.9%	-$319K	3.57%	9
2025 Q4	$36.9M	Buy	34,366 +95	+0.3%	+$90.8K	3.97%	7
2025 Q3	$26.1M	Buy	34,271 +33,040	+2,684%	+$24.6M	2.94%	10
2025 Q2	$960K	Sell	1,231 -70	-5%	-$54.4K	0.12%	48
2025 Q1	$1.07M	Buy	1,301 +207	+19%	+$172K	0.15%	48
2024 Q4	$845K	Hold	1,094	–	–	0.1%	53
2024 Q3	$969K	Buy	+1,094	New	+$984K	0.13%	51
2024 Q2	–	Sell	-1,104	Closed	-$859K	–	60
2024 Q1	$859K	Hold	1,104	–	–	0.13%	52
2023 Q4	$643K	Hold	1,104	–	–	0.1%	56
2023 Q3	$593K	Buy	1,104 +10	+0.9%	+$5.15K	0.11%	57
2023 Q2	$513K	Hold	1,094	–	–	0.09%	59
2023 Q1	$376K	Hold	1,094	–	–	0.07%	59
2022 Q4	$400K	Hold	1,094	–	–	0.08%	57
2022 Q3	$354K	Sell	1,094 -167	-13%	-$52.9K	0.08%	58
2022 Q2	$409K	Buy	1,261 +469	+59%	+$141K	0.08%	63
2022 Q1	$227K	Hold	792	–	–	0.04%	71
2021 Q4	$219K	Buy	+792	New	+$201K	0.03%	71

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stillwater Capital Advisors's LLY Position: Q1 2026 in Review

Stillwater Capital Advisors reduced its Eli Lilly (LLY) stake by 0.92% in Q1 2026, selling an estimated $319K and leaving 34,051 shares worth $31.3M. The position accounts for 3.57% of the portfolio, ranked #9.

Stillwater Capital Advisors first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $36.9M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Stillwater Capital Advisors held 34,051 shares of Eli Lilly worth $31.3M as of Q1 2026.
Stillwater Capital Advisors sold 315 Eli Lilly shares in Q1 2026, an estimated $319K.
Eli Lilly made up 3.57% of Stillwater Capital Advisors's portfolio in Q1 2026, its #9 holding.
Stillwater Capital Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
Stillwater Capital Advisors's Eli Lilly position peaked at $36.9M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stillwater Capital Advisors's 13F filing for Q1 2026, filed 10 Apr 2026.